JOADA BEST: Open Payments
NPI 1619153137 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 56 payments from 9 companies in 2025. Trend: 2023 $1,110 · 2024 $725 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 13 | $169 |
| Collegium Pharmaceutical, Inc. | 15 | $147 |
| Supernus Pharmaceuticals, Inc. | 19 | $123 |
| Insulet Corporation | 1 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Indivior Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: Azstarys, Jornay PM, Qelbree, OMNIPOD, INGREZZA, COBENFY, SUBLOCADE, ARISTADA.
Industry payments across IA — which companies pay providers there.
